Company: SMNR
Filing Date: 2025-07-28
Form Type: 425
Source: 0001213900-25-068268
Chunk: 3

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-07-28
Form: 425
Chunk 3
---
 the proxy statement of Denali for the Business Combination.

Forward-Looking Statements

This Report includes forward
looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts and may
be accompanied by words that convey projected future events or outcomes, such as “believe,” “may,”
“will,” “estimate,” “continue,” “anticipate,” “intend,”
“expect,” “should,” “would,” “plan,” “predict,”
“potential,” “seem,” “seek,” “future,” “outlook”
or variations of such words or by expressions of similar meaning. These forward-looking statements include, but are not limited to, statements
regarding future events, the Business Combination between Semnur and Denali, the estimated or anticipated future results and benefits
of the combined company following the Business Combination, including the likelihood and ability of the parties to successfully consummate
the Business Combination, future opportunities for the combined company, and other statements that are not historical facts. These statements
are based on the current expectations of management of Denali and are not predictions of actual performance. These forward-looking statements
are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee,
an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible
to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Denali. These statements are
subject to a number of risks and uncertainties regarding Denali’s businesses and the Business Combination, and actual results may
differ materially. These risks and uncertainties include, but are not limited to, general economic, political and business conditions;
the inability of the parties to consummate the Business Combination or the occurrence of any event, change or other circumstances that
could give rise to the termination of the Merger Agreement; the outcome of any legal proceedings that may be instituted against the parties
following the announcement of the Business Combination; the receipt of an unsolicited offer from another party for an alternative business
transaction that could interfere with the Business Combination; the risk that the approval of the stockholders of Semnur or the shareholders
of Denali for the potential transaction is not obtained; failure to realize the anticipated benefits of the Business Combination, including
as a result of a delay in consummating the potential transaction or difficulty in integrating the businesses of Semnur or Denali; the